India · Delayed Price · Currency is INR HDFC Life Insurance Company Earnings Call Transcripts
Fiscal Year 2026
-
Maintained top-three market position with 7% APE growth and strong retail protection gains, despite margin pressure from GST and regulatory changes. Embedded value rose to INR 62,139 crore, with a 15% operating return, and capital raise plans will further strengthen solvency.
-
Individual WRP and protection segments outpaced industry growth, with strong margin resilience despite regulatory headwinds. Persistency challenges were cohort-specific and are being addressed, while margin impact from GST is being rapidly neutralized.
-
H1-FY26 delivered 10% APE growth, 9% PAT rise, and stable margins despite GST-related headwinds. Protection and annuity segments outperformed, with strong Tier 2/3 market expansion and robust agency/broker channel growth. Margin normalization is expected by FY27.
-
Q1 FY2026 saw robust growth in APE, VNB, and profits, with market share gains and steady margins. Product mix remains balanced, and outlook is positive for H2, with continued investments in distribution and technology.
Fiscal Year 2025
-
Individual APE grew 18% and VNB rose 13% in FY 2025, with strong market share gains and robust persistency. Margins are expected to remain range-bound as investments in technology and distribution continue, while growth is projected to accelerate in H2 FY 2026.
-
Strong growth in individual WRP, VNB, and embedded value was achieved, with margins stable despite regulatory changes. Persistency improved, product mix remained balanced, and capital position is robust. Management expects continued growth and stable margins, with ongoing focus on distribution and innovation.
-
Strong H1 FY25 growth with 28% increase in individual weighted premium and 17.4% VNB growth, despite margin compression from product mix and repricing lag. Market share hit record highs, solvency improved, and robust expansion seen across channels and geographies.
-
Q1 FY25 saw 31% year-over-year growth in individual APE, strong gains in protection and non-par segments, and a 15% rise in profit after tax. Margins compressed to 25% due to product mix and investments, with regulatory changes expected to impact margins by 100 bps, though the company remains confident in its growth trajectory.